Results 271 to 280 of about 32,623 (326)

Drug-induced subacute cutaneous lupus erythematosus secondary to Dupilumab: A case report. [PDF]

SAGE Open Med Case Rep
Waugh M, Gavigan G.
europepmc   +1 more source

The Cutaneous Spectrum of Lupus Erythematosus

Clinical Reviews in Allergy and Immunology, 2017
Systemic lupus erythematosus is a complex autoimmune disease with a wide spectrum of clinical and immunopathological features. Cutaneous and articular manifestations are the most common signs in patients with systemic lupus erythematosus. We here review the pathogenesis and the new classification of cutaneous lupus erythemathosus with a discussion of ...
Simone Ribero, Savino Sciascia, D Lipsker   +2 more
exaly   +5 more sources

Cutaneous lupus erythematosus

, 2016
Cutaneous lupus erythematosus (LE) is an autoimmune disease. The most common clinical forms are acute cutaneous LE (ACLE), subacute cutaneous LE (SCLE) and discoid LE (DLE). Cutaneous LE, mainly ACLE, can be the first sign of systemic LE (SLE).
Annegret Kuhn, Aysche Landmann, Gisela Bonsmann   +2 more
core   +3 more sources

Drug-induced subacute cutaneous lupus erythematosus

Lupus, 2010
Subacute cutaneous lupus erythematosus (SCLE) is a subset of cutaneous lupus erythematosus with unique immunologic and clinical features. The first description dates back to 1985 when a series of five patients were found to have hydrochlorothiazide ...
J P Callen
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Cutaneous Lupus Erythematosus in Children

Current Pediatric Reviews, 2021
Background:The skin is commonly involved in autoimmune diseases, such as lupus erythematous. The cutaneous lupus erythematosus (CLE) can manifest with or without systemic symptoms. It is advantageous from a patient and healthcare system standpoint for early diagnosis and intervention. Prevention of complications is especially important in the pediatric
Vivian Tsang, Alexander K.C. Leung, Joseph M. Lam   +2 more
openaire   +2 more sources

Cutaneous Lupus Erythematosus

American Journal of Clinical Dermatology, 2003
Cutaneous lupus erythematosus (CLE) includes a variety of lupus erythematosus (LE)-specific skin lesions that are subdivided into three categories - chronic CLE (CCLE), subacute CLE (SCLE) and acute CLE (ACLE) - based on clinical morphology, average duration of skin lesions and routine histopathologic examination.
FABBRI, PAOLO, C. Cardinali, B. Giomi, M. Caproni   +3 more
openaire   +3 more sources

Chronic Cutaneous Lupus Erythematosus

Medical Clinics of North America, 1989
Chronic cutaneous LE is a diverse disease, characterized by predominantly cutaneous disease with few systemic complications. Discoid lesions are commonly seen, but they are not specific for chronic cutaneous LE. These scarring and disfiguring changes are also present in neonatal LE, SLE, and complement deficiency LE. Because definitive diagnosis cannot
S R, Hymes, R E, Jordon
openaire   +2 more sources

Treatment of cutaneous lupus erythematosus

Lupus, 2010
In patients with cutaneous lupus erythematosus (CLE) and mild skin involvement, local therapy consisting of topically applied pharmacological agents, e.g., topical/intralesional steroids, may be sufficient. Recent reports have also shown efficacy of topical calcineurin inhibitors in patients with CLE, particularly on the face ...
A, Kuhn, F, Ochsendorf, G, Bonsmann
openaire   +2 more sources

Thalidomide in Cutaneous Lupus Erythematosus

American Journal of Clinical Dermatology, 2003
For nearly 50 years, thalidomide has struggled between success and controversy. After causing an epidemic of phocomelia and other birth defects during the 1960s, affecting thousands of neonates, thalidomide was used as a sedative in selective disorders including leprosy.
Michelle T, Pelle, Victoria P, Werth
openaire   +2 more sources